Charles River Laboratories International (CRL) Equity Income (2012 - 2016)

Charles River Laboratories International's Equity Income history runs 5 years deep, the most recent figure standing at $442000.0 for Q3 2016.

• In Q3 2016, Equity Income fell 86.36% year-over-year to $442000.0; the TTM figure through Sep 2016 stood at $8.7 million (up 58.08% YoY), while the FY2015 annual figure was $3.8 million, down 58.89% from the prior year.
• Equity Income was $442000.0 for Q3 2016 at Charles River Laboratories International, down from $5.0 million in the prior quarter.
• In the past five years, Equity Income ranged from a high of $6.1 million in Q1 2014 to a low of -$907000.0 in Q2 2015.
• Historically, Equity Income has averaged $1.4 million across 5 years, with a median of $1.1 million in 2013.
• The sharpest annual moves came in 2014 and 2015: Equity Income surged 6882.22% in 2014, then plunged 143.69% in 2015.
• A 5-year view of Equity Income shows it stood at -$373000.0 in 2012, then surged by 386.33% to $1.1 million in 2013, then surged by 80.06% to $1.9 million in 2014, then slumped by 88.61% to $219000.0 in 2015, then surged by 101.83% to $442000.0 in 2016.
• The last three Equity Income figures came in at $442000.0 (Q3 2016), $5.0 million (Q2 2016), and $3.1 million (Q1 2016), per Business Quant data.